SEATTLE–(BUSINESS WIRE)–Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low oxygen levels in cells to prevent organ failure, announced the recent …
Category: Business
EnChroma Names Vision Industry Veteran Erik Ritchie as CEO
BERKELEY, Calif.–(BUSINESS WIRE)– #colorforall–EnChroma Names Vision Industry Veteran Erik Ritchie as CEO – Former Zenni Optical Executive to Guide Leader in Solutions for Color Blindness
2020 On-site Mobile Clinic Achieves Excellent Air Quality and Professional Standards with STERIS and Emmes Optym Certification
BOSTON–(BUSINESS WIRE)–2020 On-site is the first mobile clinic in the industry to receive certifications from Emmes Optym and STERIS.
Global Visual Impairment Market to Surpass US$ 8,130.3 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE–(BUSINESS WIRE)– #Blindness–North America is estimated to hold the largest market share in the global visual impairment market in 2020.
Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of AcrySof IQ VivityTM, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of AcrySof IQ VivityTM, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Keratoconus Epidemiology Forecast Report 2017-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconus – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Keratoconus (KC) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, hist…
Kopin Corporation Ships First Production Order of 720p Color OLED Microdisplays
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of high-resolution microdisplays and display subassemblies for defense, enterprise, industrial, consumer and medical products, announced today it h…
Samsara Vision Appoints Three New Members to the Board of Directors
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision is pleased to announce the appointment of three new members to its Board of Directors.
Midwest Vision Partners Announces Partnership With Parschauer Eye Center
CHICAGO & SANDUSKY, Ohio–(BUSINESS WIRE)– #eyecare–Midwest Vision Partners announces its 8th partnership to date with Parschauer Eye Center, expanding its network to 95+ physicians and 44 locations.
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will participa…
The Donate Life Community, Along With NJ Sharing Network and 14 Other Sponsors From Around the Nation, Invite Audiences to Watch the 2021 Rose Parade TV Special on New Year’s Day
LOS ANGELES–(BUSINESS WIRE)– #2021RoseParade–The Donate Life Community, NJ Sharing Network and 14 other sponsors invite audiences to watch the 2021 Rose Parade TV special on New Year’s Day.
Global Contact Lens Market Insights & Forecast 2020-2024 with COVID-19 Impact Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market is forecasted to reach US$9.92 b…
VisionQuest Biomedical Inc. Gains FDA 510(k) Clearance for the Image Quality Analyzer Software
ALBUQUERQUE, N.M.–(BUSINESS WIRE)– #510k–VisionQuest Biomedical Inc. (VisionQuest) announced today that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the Image Quality Analyzer (IQA) so…
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
NEW YORK–(BUSINESS WIRE)– #FDA–Eyenovia has submitted an NDA to the FDA for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent delivered by the Optejet dispenser.
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market Research 2020-2024 | Post-Pandemic Industry Planning Structure by Technavio
LONDON–(BUSINESS WIRE)– #GlobalLaserAssistedInSituKeratomileusisLASIKSurgeryMarket–The Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market will grow by $ 375.04 mn during 2020-2024
United Kingdom Spectacles and Googles Market Outlook to 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United Kingdom: Spectacles and Googles 2014-2024” report has been added to ResearchAndMarkets.com’s offering. This report forecasts the market evolution at an average annual rate of -6.5% to the level of 205,010 thousand e…
EyeSouth Partners Expands Presence in Houston with Eye Center of Texas Affiliation
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Eye Center of Texas (“ECT”). The affiliation represents EyeSouth’s third in the state of Texas and twentieth affi…
Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase III Studies for Diabetic Macular Edema, a Leading Cause of Blindness
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global Phase III studies, YOSEMITE and RHINE, evaluating its invest…